Ryan Dolan1, Amir Rahsepar1, Julie Blaisdell1, Kai Lin1, Kenichiro Suwa1, Allen Anderson2, Kambiz Ghafourian2, Esther Vorovich2, Jonathan Rich2, Jane Wilcox2, Clyde Yancy2, Jeremy Collins1, James Carr1, and Michael Markl1
1Radiology, Northwestern University, Chicago, IL, United States, 2Cardiology, Northwestern University, Chicago, IL, United States
Synopsis
Cardiac MRI demonstrates differences between heart
transplant recipients and controls using tissue phase mapping (TPM), T2, and
T1. Significant correlations between myocardial
velocities and dyssynchrony obtained from TPM (myocardial function) and T2 and
T1 (myocardial tissue structure) suggest a relationship between impaired
structure and function among transplant recipients.
Introduction
Following heart transplantation (Tx), recipients are monitored
with frequent endomyocardial biopsies (EMB), echocardiograms, and office visits
to detect histopathologic, functional, or symptomatic evidence of common causes
of mortality [1], but each of these modalities has limitations. The current gold standard screening tool for
ACAR is EMB, but it is invasive and has limited sensitivity due to sampling
error [2]. Cardiac magnetic resonance
imaging (CMR) has shown promise as an alternative imaging modality due to its
capacity to quantify regional changes in left ventricular (LV) tissue morphology
and function. The goal of this study was to apply three complementary CMR techniques
for the assessment of relationships between altered myocardial tissue structure
and function: tissue phase mapping (TPM) for measurement of regional LV
velocities [3,4], pre- and post-Gd T1-mapping for assessment of fibrosis by
extracellular volume fraction (ECV) [5], and T2-mapping for myocardial edema
quantification [4,6,7]. Our hypotheses
were that 1) TPM can detect changes in myocardial function compared to
controls, 2) T2-mapping, T1-mapping, and ECV fraction can detect changes in
myocardial structure compared to controls, and 3) LV structural abnormalities
are associated with impaired LV function.Methods
Seventy Tx recipients (age 50.6±17.2 years, female 43%) were prospectively
recruited for 98 total scans (6.4±6.2 years post Tx, 23% within 1yr
post Tx) from 2014-2016. Eighteen age-matched
healthy controls (age 50.1±16.1
years, female 33%) were also recruited, and a scan from each was included in
the study (TPM was only included in 10 controls). All patients underwent CMR at 1.5T (Magnetom Aera
or Avanto, Siemens, Erlangen, Germany). Measures
of LV systolic function (EDV, ESV, SV, HR, CO, EF, end diastolic myocardial
mass) were calculated from a stack of 2D cine SSFP images of the LV using dedicated
software (cvi42, v 5.3.6, Circle, Calgary, Canada). In addition, T2-mapping, as well as native
and post-Gd T1-mapping (to generate ECV using hematocrit drawn at the time of
CMR) were performed in short axis orientation at the LV base, mid, and apex. Finally, TPM data acquisition used a
black-blood cine 2D phase-contrast sequence with tri-directional velocity
encoding for the LV base, mid, and apex (venc=25 cm/s, temporal resolution=24 ms,
spatial resolution=2.0x2.0 mm²). Data analysis
included the calculation of T2, native T1, and ECV maps and LV segmentation to
quantify global and regional T2, T1, and ECV (cvi42, v5.3.6, Circle, Calgary,
Canada). TPM analysis included
semi-automated identification of endo-and epi-cardial LV contours throughout
the cardiac cycle and calculation of radial and longitudinal LV peak velocities
and time to peak velocity (TTP) using an in-house tool (Matlab, Mathworks,
Natick, MA). Dyssynchrony was calculated
using the standard deviation of TTP in radial and longitudinal directions.Results
Comparisons between Tx recipients and controls are shown
in Table 1. Tx recipients had nearly 50%
higher heart rates compared to controls (p<0.001), an expected result of
cardiac denervation during Tx. Tx
recipient SVs were lower than in controls (p=0.044), but CO was increased (p=0.022). TPM results showed equivalent or better LV
function in the radial direction, but significantly worse function
longitudinally: peak longitudinal velocity was significantly decreased compared
to controls during both systole and diastole (p<0.001, p=0.038), and systolic
longitudinal dyssynchrony was also significantly increased (p<0.001). All T2 parameters (global, peak, septal,
lateral, 3 slices) were significantly elevated in Tx recipients compared to controls
(all p<0.001), indicating increased levels of edema in Tx patients. All native T1 parameters (global, peak,
septal, lateral, 3 slices) were significantly increased as well (p=0.010 to 0.049),
but there were no differences in ECV. Correlation
analysis results between TPM and T2, T1, and ECV are summarized in Table
2. A significant inverse relationship
was found between all T2 parameters and peak systolic longitudinal velocity
(global r=-0.43, p<0.001). T2 also correlated
with systolic longitudinal dyssynchrony (r=0.25, p=0.021). Peak, septal, and basal T1 were associated
with systolic radial dyssynchrony (r=0.27, p=0.012; r=0.26, p=0.015; r=0.27, p=0.014).Conclusion
Despite similar normal global LV function, TPM,
T2-mapping, and T1-mapping each showed differences between control and Tx
hearts. TPM showed lower longitudinal
velocities and more dyssynchrony among Tx patients, but no impairment
radially. Significantly higher T2 in Tx
patients indicates more edema and inflammation in transplanted hearts at
baseline, and higher T1 in Tx patients suggests diffuse fibrotic interstitial disease in these hearts. Correlations
between T2 and TPM, as well as T1 and TPM, provide evidence of a relationship
between impaired structure and function following Tx.Acknowledgements
Grant
support by NHLBI R01 HL117888.References
1. Costanzo MR, et al. The International Society of Heart
and Lung Transplantation guidelines for the care of heart transplant
recipients. J Heart Lung Transplant 2010; 29:914-956.
2. Fishbein MC, Kobashigawa J. Biopsy-negative cardiac
transplant rejection: Etiology, diagnosis, and therapy. Curr Opin Cardiol.
2004; 19:166-169.
3. Foll D, et al. Magnetic resonance tissue phase mapping
of myocardial motion: New insight in age and gender. Circ Cardiovasc Imaging
2010; 3:54-64.
4. Markl M, et al. Myocardial T2-mapping and velocity
mapping: Changes in regional left ventricular structure and function after
heart transplantation. Magn Reson Med. 2012, published online.
5. Lee JJ, et al. Myocardial T1 and extracellular volume
fraction mapping at 3 Tesla. J Cardiovasc Magn Reson. 2011; 13:75.
6. Giri S, et al. T2 quantification for improved
detection of myocardial edema. J Cardiovasc Magn Reson. 2009; 11:56.
7. Usman AA, et al. Cardiac magnetic resonance T2 mapping
in the monitoring and followup of acute cardiac transplant rejection: A pilot
study. Circ Cardiovasc Imaging 2012; 5:782-790.